SCHEMBL8286408

SCHEMBL8286408

CCNC(=O)COc1cc(C)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.41
PDE11A Q9HCR9 1/20 0.40
KDM4E B2RXH2 1/20 0.39
CSF1R P07333 1/20 0.38
POLB P06746 1/20 0.37
HTT P42858 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HCRTR1 O43613 1/20 0.36
LMNA P02545 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
UBE2N P61088 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287417 0.91 HTT (0.47) RAB9APDE11AKDM4EHTTSMN1; SMN2
SCHEMBL8286366 0.90 PDE11A (0.43) PDE11AKDM4ECSF1RPOLBHTT
SCHEMBL8286402 0.88 ALDH1A1 (0.43) RAB9APDE11AKDM4ECSF1RPOLB
SCHEMBL8286418 0.87 LDHA (0.45) RAB9APDE11AKDM4EHTTALDH1A1
SCHEMBL8361762 0.83 OPRK1 (0.41) RAB9APDE11AKDM4ECSF1RPOLB
SCHEMBL8286379 0.82 PDE11A (0.43) PDE11AKDM4EPOLBALDH1A1LMNA
SCHEMBL8286356 0.82 CYP3A4 (0.41) RAB9APDE11AKDM4EPOLBHTT
SCHEMBL8287532 0.82 PDE11A (0.51) PDE11AKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL8287832 0.81 PDE11A (0.47) PDE11AKDM4EPOLBHTTSMN1; SMN2
SCHEMBL8286383 0.81 PDE11A (0.51) PDE11AKDM4ECSF1RPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed